openPR Logo
Press release

The Drug of Abuse Testing Market is projected to reach a valuation of US$ 1.5 Bn in 2021, with sales growing at above 5% CAGR through 2031

12-08-2021 10:58 AM CET | Health & Medicine

Press release from: Future Market Insights

The current study by Future Market Insight (FMI) unveiled that the revenue of global drug of abuse testing market is expected to reach US$ ~2,210 Mn, by the end of 2029. During the forecast period of 2019-2029, the Drug of Abuse Testing Market is estimated to record a ~5% CAGR. Increasing focus on public healthcare will contribute to the build-up of drug of abuse testing market by the end of 2029, as revealed in the report.

Rising Demand for Drug of Abuse Testing from Private Employers to Benefit the Market

Owing to reduced productivity of individuals using illicit drugs, several employers emphasize on regulating workforce by drug abstinence through conducting regular drug of abuse testing. As individuals using illicit drugs are more likely to change jobs, be less productive, be absent frequently, and are more likely to get involved in a workplace accident, the demand for drug of abuse testing has increased by multiple folds in private as well as public workplaces, which is expected to provide boost to the global drug of abuse testing market over the forecast period.

For instance, according to the claims of the U.S. Navy, random drug of abuse testing conducted in its drug-free workplace programs has reduced nearly 57% of drug and alcohol abuse among sailors.

Similar programs in several organizations are likely to create high growth opportunities for drug of abuse testing market players over the forecast period.

Get Report Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1649

Growing Abuse of Prescription Drugs to Aid the Market Growth

Growth in the prescription drug abuse is skyrocketing and in turn is increasing the rate of overdose deaths and emergency room visits, thereby potentially raising the demand for drug of abuse testing services. The nonmedical consumption of prescription drugs is growing very rapidly; according to National Survey on Drug Use and Health (NSDUH), an estimated 2.4 million people in the U.S. use prescription drugs for nonmedical purpose. Such factors are likely to lead to increased demand for drug of abuse testing.

The high rate of comorbid illnesses are also responsible for wrong prescription and addiction to prescription drugs among older populations. Continuous growth in the abuse of prescription drugs is expected to propel demand for drug of abuse testing services globally.

Prescription for Drug of Abuse Testing for Senior Citizens Seeking Pain Management Treatment

Physicians providing treatment for pain management to the senior citizens are prescribing various drug of abuse testing drugs prior to the treatment, which is a lucrative business for physicians for obtaining reimbursement from services including Centers for Medicare & Medicaid Services (CMS).

For instance, in 2012, Medicare spent nearly US$ 445 million on drug of abuse testing, which is creating a lucrative opportunity for the physicians and drug of abuse testing providers. Physicians are also earning through reimbursement by conducting tests in their own offices, which is creating a lucrative opportunity for the drug of abuse testing market players.

Speak To Analyst For Queries about Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-1649

Changing Population Dynamics to Change Drug of Abuse Testing Market Scenario

Growing number of drug and alcohol abusers worldwide is expected to provide high growth opportunities for stakeholders in the drug of abuse testing market.

According to National Institute of Drug Abuse, alcohol, tobacco, and illicit drugs together create an economic burden of nearly US$ 700 billion in the U.S. through related costs and healthcare expenditure. Thus, it is highly likely to propel the demand for drug of abuse testing in the coming years.

Further, according to the United Nations Office of Drug and Crime, more than 5% of the global population in the age group of 15 to 64 years use illicit drugs, and nearly 32.4 million people globally use pharmaceutical opioids and opiates. Such factors pave the way for lucrative growth of the drug of abuse testing market, and the trend is likely to continue over the forecast period.

This study underlines key opportunities in the drug of abuse testing market and finds that the market would exhibit growth at a value CAGR of ~5% during forecast period.

Buy Industry Research Report: https://www.futuremarketinsights.com/checkout/1649

Reasons to Buy the report

We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

Contact

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Drug of Abuse Testing Market is projected to reach a valuation of US$ 1.5 Bn in 2021, with sales growing at above 5% CAGR through 2031 here

News-ID: 2489704 • Views:

More Releases from Future Market Insights

Eye Health Ingredients Market to Reach USD 360.3 Million by 2035, Driven by 7.5% CAGR and Rising Demand for Carotenoids and Omega Compounds
Eye Health Ingredients Market to Reach USD 360.3 Million by 2035, Driven by 7.5% …
The global eye health ingredients industry is projected to reach USD 360.3 million by 2035, expanding from USD 174.8 million in 2025 at a CAGR of 7.5%. Growth is fueled by increasing consumer awareness around preventive eye health, heavy screen exposure, and rising age-related vision issues. As consumers adopt nutraceuticals, fortified foods, and ocular supplements, demand for carotenoids, omega-based compounds, and botanical extracts continues to scale across retail and healthcare
Global Grapeseed Oil Market Set for 4.1% CAGR, Expected to Hit USD 809.3 Million by 2035
Global Grapeseed Oil Market Set for 4.1% CAGR, Expected to Hit USD 809.3 Million …
The global grapeseed oil market is projected to grow from USD 541.5 million in 2025 to USD 809.3 million by 2035, registering a CAGR of 4.1%. Rising demand across culinary, personal care, and nutraceutical applications is elevating its market value due to its rich antioxidant profile, vitamin E content, and plant-based origin. Health-conscious consumers are increasingly choosing grapeseed oil for premium cooking and natural skincare, while manufacturers expand cold-pressing capacities to
Soybean Enzymatic Protein Market Set to Reach USD 5.2 Billion by 2035, Driven by 7.8% CAGR
Soybean Enzymatic Protein Market Set to Reach USD 5.2 Billion by 2035, Driven by …
The global soybean enzymatic protein market is moving into a phase of rapid commercial adoption, projected to expand from USD 2.4 billion in 2025 to USD 5.2 billion by 2035, registering a CAGR of 7.8%. What began as a niche application segment during 2020-2024 has now matured into a scalable, mainstream protein category integrated into beverages, functional foods, meat alternatives, and nutritional supplements. Between 2025 and 2030, the market enters its
Global Squid Market to Reach USD 18.4 Billion by 2035, Driven by 3.8% CAGR Growth
Global Squid Market to Reach USD 18.4 Billion by 2035, Driven by 3.8% CAGR Growt …
The global squid market, valued at USD 12.7 billion in 2025, is projected to reach USD 18.4 billion by 2035, reflecting a 3.8% CAGR, driven by rising seafood demand, diversified product formats, and robust food supply chains. Steady consumption growth across Asia-Pacific, Europe, and North America continues to uplift commercial fishing, aquaculture, and value-added squid processing. Growth momentum between 2021 and 2025 shows a consistent upward curve, with the market expanding

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase